An epithelial-mesenchymal cell transformation (EMT) occurs during the development of endocardial cushions in the atrioventricular (AV) canal of the heart. This is a complex developmental process regulated by multiple extracellular signals and signal transduction pathways. It was recently shown that the transcription factor Slug is expressed in the AV canal and is required for initial steps of EMT. Treatment of AV canal explants with either antisense oligodeoxynucleotides toward Slug or anti-TGF␤2 antibody inhibited initial steps of EMT. Others have identified roles for HGF and BMP during EMT in the heart. Both HGF and BMP are known to regulate Slug in other cell types. To determine whether TGF␤2 or other signaling factors regulate Slug expression during EMT in the heart, we cultured AV canal explants in the presence of anti-TGF␤2 antibody, anti-TGF␤3 antibody, pertussis toxin, retinoic acid, noggin, or anti-HGF antibody. Only treatment with anti-TGF␤2 antibody or retinoic acid inhibited Slug expression in AV canal explants. Consistent with these data, we found that retinoic acid disrupted initial steps of EMT, while antagonists of BMP and HGF signaling disrupted later steps of EMT. Transfection of AV canal explants with Slug rescued the inhibitory effect of anti-TGF␤2 antibody but not retinoic acid on EMT. Slug is thus an essential target of TGF␤2 signaling during EMT in the developing chicken heart.
INTRODUCTION
Early in embryonic development, the vertebrate heart is a hollow tube composed of an outer layer of myocardium and an inner layer of endocardium separated by extracellular matrix (ECM). As cardiac morphogenesis proceeds, endocardial cushions develop within the atrioventricular (AV) canal. The endocardial cushions initially consist only of ECM (Krug et al., 1987) . Later, in response to an inductive signal emitted by AV canal myocardium (Runyan and Markwald, 1983; Krug et al., 1985 Krug et al., , 1987 , a portion of the endothelial cells lining the endocardial cushions undergo an epithelialmesenchymal cell transformation (EMT) and migrate into the underlying ECM (Kinsella and Fitzharris, 1980) . Endocardial cushion tissue eventually contributes to the leaflets of the mitral and tricuspid valves, as well as to the interatrial and interventricular septa (Markwald et al., 1984; Chin et al., 1992) . Therefore, the study of EMT is critical to understanding how certain heart defects arise in humans.
The zinc finger protein Slug is a member of the Snail family of related transcription factors (Nieto et al., 1994) .
Slug is expressed by AV canal endothelial cells, as well as by mesenchymal cells within the endocardial cushions. In vitro experiments demonstrated that Slug is required for AV canal endothelial cells to undergo initial steps of EMT. Treatment of chicken AV canal explants with antisense Slug oligodeoxynucleotides inhibited mesenchymal cell formation. Specifically, antisense treatment prevented endothelial cell-cell separation, suggesting that Slug acts early in the EMT pathway (Romano and Runyan, 1999) .
Slug also is required for the EMTs that occur during gastrulation and neural crest differentiation in chicken embryos. Epiblast cells flanking the primitive streak express Slug as they transform into mesenchymal cells and migrate down into the blastocoel during gastrulation. Presumptive neural crest cells express Slug as they transform into mesenchymal cells and migrate from the dorsal region of the neural tube. When stage 4 -9 chicken embryos were cultured in vitro in the presence of antisense Slug oligodeoxynucleotides, mesoderm formation was impaired. Likewise, presumptive neural crest cells failed to transform into mesenchyme, resulting in a wide range of defects (Nieto et al., 1994) . It has been proposed that Slug regulates the expression of genes required for the changes in cell adhesion and cytoskeletal organization necessary for epithelial cells to transform into migratory mesenchymal cells. Slug also may play a role in maintaining the mesenchymal cell phenotype in tissues such as the limb bud (Buxton et al., 1997; Ros et al., 1997) .
Several signaling factors are good candidates for regulating Slug expression in the heart. For instance, TGF␤2, a member of a large superfamily of related growth factors, is expressed in both AV canal myocardium and endocardium (Potts et al., 1992; Boyer et al., 1999a) . Treatment of AV canal explants with anti-TGF␤2 antibody inhibited initial steps of EMT including endothelial cell-cell separation (Boyer et al., 1999a) . G i proteins regulate intracellular signaling events by inhibiting adenylate cyclase in response to activation of a G-protein-linked receptor. Treatment of AV canal explants with pertussis toxin, an antagonist of G i protein signaling, also inhibited initial steps of EMT (Runyan et al., 1990; Boyer et al., 1999a) . In contrast, treatment of AV canal explants with anti-TGF␤3 antibody inhibited later steps of EMT including mesenchymal cell migration (Boyer et al., 1999a) .
Retinoic acid also is a candidate for regulating Slug expression in the heart, although an endogenous source of retinoic acid is unknown. Mice exposed to inappropriate levels of retinoic acid, or which have a null mutation for the retinoid X receptor-alpha (RXR␣), exhibit AV septal defects (Gruber et al., 1996 ; reviewed by Smith et al., 1998) . BMPs and HGF have been shown to regulate AV canal development and therefore, may regulate Slug expression as well. It appears that BMP2 and TGF␤3 act synergistically to mediate certain steps of EMT in the AV canal (Yamagishi et al., 1999; Nakajima et al., 2000) . HGF appears to regulate mesenchymal cell migration (Song et al., 1999) . It is especially important to consider BMPs and HGF as candidates for regulating Slug expression in the heart since these growth factors have been shown to regulate Slug expression in other tissues (Liem et al., 1995; Savagner et al., 1997; Selleck et al., 1998) .
To identify specific signaling factors that regulate Slug expression during EMT in the heart, we cultured AV canal explants in the presence of anti-TGF␤2 antibody, anti-TGF␤3 antibody, pertussis toxin, retinoic acid, noggin, or anti-HGF antibody. Semiquantitative RT-PCR and immunostaining demonstrated that only treatment with anti-TGF␤2 antibody or retinoic acid inhibited Slug expression in AV canal explants. Consistent with these data, we found that treatment of AV canal explants with retinoic acid inhibited initial steps of EMT in a dose-dependent manner. Treatment of explants with noggin (an antagonist of BMP signaling) or anti-HGF antibody inhibited later steps of EMT. Addition of exogenous BMP-2 or HGF rescued the inhibitory effects of noggin or anti-HGF antibody, respectively, on transformation.
Transfection of AV canal explants with Slug rescued the inhibitory effect of anti-TGF␤2 antibody but not retinoic acid on EMT. Therefore, Slug is an essential target of TGF␤2 signaling during EMT in the developing chicken heart. We speculate that TGF␤2 regulates Slug expression via activation of the Type III TGF␤ receptor, which is required for initial steps of EMT (Brown et al., 1999) . We also suggest that Slug was not sufficient to overcome the inhibitory effect of retinoic acid on EMT because it is only one of several genes in the heart disrupted by retinoic acid exposure.
MATERIALS AND METHODS

Treatment of AV Canal Explants with Signaling Factors or Signaling Factor Antagonists
Collagen gels were prepared according to Potts and Runyan (1989) : 1 ml of rat tail collagen (approximately 3.5 mg/ml) diluted 1:1 in water was mixed with 200 l of 2.2% sodium bicarbonate (Sigma, St. Louis, MO) diluted 1:1 in 10ϫ Medium 199 (Gibco BRL, Gaithersburg, MD). Two hundred eighty microliters of the collagen solution was poured into each well of a Nunclon MultiDish culture dish (Nunc, Roskilde, Denmark) and allowed to solidify for at least 15 min at room temperature. Five hundred microliters of medium was applied to the collagen gels for at least 1 h at 37°C in a tissue culture incubator prior to use.
Fertilized White Leghorn chicken eggs (Rosemary's Farm, Santa Monica, CA) were incubated at 37°C to obtain embryos, which were staged according to Hamburger and Hamilton (1951) . AV canals were dissected from embryonic chicken hearts in Tyrode's solution (Sigma) and cut open to expose the inner endocardial surface. The explants were placed on collagen gels so that the endocardium was in contact with the surface of the gel to facilitate endothelial cell outgrowth. After approximately 6 h of incubation at 37°C in a tissue culture incubator, the following signaling factors or signaling factor antagonists were applied to the explants: polyclonal anti-chicken TGF␤2 antibody (R&D Systems, Minneapolis, MN) (10 g/ml) diluted in 300 l of Medium 199, 300 l of monoclonal anti-chicken TGF␤3 antibody supernatant (Developmental Studies Hybridoma Bank, University of Iowa), pertussis toxin (Sigma) (10 ng/ml) diluted in 300 l of Medium 199, retinoic acid (Sigma) (10 ng/ml) diluted in 300 l of Medium 199, 300 l of noggin-containing or control conditioned medium diluted 1:1 in Medium 199, or a polyclonal anti-human HGF antibody (R&D Systems) (10 g/ml). Conditioned medium was prepared using parental Chinese hamster ovary (CHO) cells or CHO cells stably expressing Xenopus noggin (Smith and Harland, 1992) . Dr. Richard Harland (University of California at Berkeley) kindly provided CHO cells. A range of retinoic acid concentrations was tested (0.5-300 ng/ml) (data not shown). Retinoic acid at a concentration of 10 ng/ml proved to most effectively inhibit EMT without any visible signs of toxicity.
After 24 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant under an Olympus inverted microscope. Observation under the microscope revealed that both control and treated explants were viable and that the myocardium was beating. A t test, two-sample assuming unequal variances, was performed to compare control and treated groups of explants (Microsoft Excel software).
Semiquantitative RT-PCR
After 24 h of incubation, total RNA was extracted from selected AV canal explants using RNA Stat-60 (Tel-Test "B", Inc., Friendswood, TX) and treated with DNase (Gibco BRL). RT-PCR was then performed. The total volume for each reverse transcription reaction was 30 l for 2 g of RNA. The reaction also included 1.5 l of random primers (Gibco BRL), 1 l of 10 mM dNTPs (Gibco BRL), 20 U of rRNasin RNase inhibitor (Promega, Madison, WI), and 400 U of M-MLV reverse transcriptase in 5ϫ First Strand Buffer supplied with the enzyme (Gibco BRL). cDNA was synthesized in a PTC-100 programmable thermal controller (MJ Research, Inc., Watertown, MA) under the following conditions: a 1.5-h incubation at 37°C and a 10-min incubation at 75°C.
Specific primers were designed to amplify a 358-bp Slug sequence by PCR. The primer sequences were 5Ј CTGCCT-TCAAAATGCCAC (bp 1-14) and 3Ј TTGGACTGGATTCTCTCT (bp 341-358). The total volume for each PCR was 50 l. The reaction included 0.1 g of each specific primer (Integrated DNA Technologies, Inc., Coralville, IA), 0.1 g of cDNA, 1 l of 10 mM dNTPs (Gibco), 3 l of 25 mM magnesium chloride (Fisher Scientific, Pittsburgh, PA), and 2.5 U of Taq DNA Polymerase in 10ϫ Assay Buffer B supplied with the enzyme (Fisher Scientific). PCR was performed in a PTC-100 programmable thermal controller under the following conditions: 30 s denaturation at 92°C, 1 min annealing at 58°C, and 1.5 min extension at 72°C. As a control for loading, RT-PCR also was performed using specific primers designed to amplify an 800-bp glyceraldehyde-3-phosphate dehydrogenase (GAPDH) sequence.
The PCR products were fractionated on a 1% agarose gel and visualized using ethidium bromide. Band densities were quantitated using NIH Image analysis software. The background density of the gel was subtracted from the peak density for each band. The area of each band measured was then multiplied by the adjusted band density to determine relative amplification levels. Twentyseven cycles was determined to be within the linear range of both Slug and GAPDH amplification by removing and analyzing aliquots from a series of cycles (20 -35). RT-PCR was then repeated for 27 cycles using RNA collected from both control and treated explants. Slug and GAPDH band densities were quantitated using NIH Image analysis software as described above. Slug band densities were normalized to GAPDH levels in the same RNA samples. The RT-PCR experiment was performed four times and average Slug band densities were obtained. The average Slug band densities obtained from treated AV canal explants were plotted relative to the average Slug band density obtained from control AV canal explants, which was arbitrarily set at 1.
Immunostaining of AV Canal Explants
After 24 h of incubation, selected AV canal explants were rinsed with Tyrode's solution for 30 min at room temperature and fixed with 2% paraformaldehyde overnight at 4°C. After fixation, the explants were rinsed with 1ϫ PBS for 1 h at room temperature. To block nonspecific binding sites, 1ϫ PBS containing 1% bovine serum albumin (Sigma) and 2% donkey serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) was applied to the explants for 30 min at 37°C. Blocking solution containing 0.2% Tween (Sigma) was then applied to the explants overnight at 4°C. A monoclonal anti-chicken Slug antibody (Developmental Studies Hybridoma Bank) was diluted 1:100 in 1ϫ PBS containing 0.5% bovine serum albumin, 1% donkey serum, and 0.2% Tween and applied to the explants for 2 h at 4°C. Alternatively, mouse IgG (Jackson ImmunoResearch Laboratories, Inc.) (1 g/ml) diluted in 1ϫ PBS containing 0.5% bovine serum albumin, 1% donkey serum, and 0.2% Tween was applied to some of the explants as a negative control. After incubation with the primary antibody, the explants were rinsed with 1ϫ PBS containing 0.2% Tween for 2 h at room temperature. AffiniPure rabbit anti-mouse IgG (HϩL) (Jackson ImmunoResearch Laboratories, Inc.) (10 g/ml) was diluted in 1ϫ PBS containing 0.2% Tween and applied to the explants for 30 min at 4°C. After incubation with the secondary antibody, the explants were rinsed as previously described. Finally, Cy5-conjugated AffiniPure goat anti-rabbit IgG (HϩL) (Jackson ImmunoResearch Laboratories, Inc.) was diluted 1:300 in 1ϫ PBS containing 0.2% Tween and applied to the explants for 45 min at 4°C. After incubation with the tertiary antibody, the explants were rinsed with 1ϫ PBS containing 0.2% Tween for 2 h at room temperature and then with 1ϫ PBS for 30 min at room temperature. After the explants were rinsed with water, the collagen gels were transferred to glass slides. Coverslips were mounted using glycerol gelatin and sealed with nail polish. The slides were stored in the dark at 4°C until viewed under a Leica confocal microscope.
Transfection of AV Canal Explants with Slug cDNA
Full-length chicken Slug cDNA (provided by Dr. Thomas Jessell at Columbia University, New York) was cloned into pIRES2-EGFP vector (Clontech, Palo Alto, CA) using EcoRI and BamHI restriction enzymes (Gibco BRL). A mixture of plasmid DNA and Lipofectamine reagent (Gibco BRL) was prepared as follows: 12 g of plasmid DNA (pIRES2-EGFP or Slug-pIRES2-EGFP) was diluted in 100 l of Medium 199 (Gibco BRL). Twelve microliters of Lipofectamine reagent was also diluted in 100 l of Medium 199. The plasmid DNA and Lipofectamine reagent solutions were mixed and incubated for 15 min at room temperature. An additional 800 l of Medium 199 was then added to the mixture.
Collagen gels were prepared as described above. AV canals were dissected from stage 14 embryonic chicken hearts in Tyrode's solution (Sigma) and cut open to expose the inner endocardial surface. The explants were incubated in the mixture of plasmid DNA and Lipofectamine reagent for 30 min at 37°C in a tissue culture incubator. After 30 min of incubation, the explants were placed on collagen gels and returned to the tissue culture incubator. After approximately 6, 18, and 30 h of incubation, a polyclonal anti-chicken TGF␤2 antibody (R&D Systems) (10 g/ml) or retinoic acid (Sigma) (10 ng/ml) diluted in 300 l of Medium 199 was applied to the explants. After 48 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant under an Olympus inverted microscope. Observation under the microscope revealed that transfected explants were viable and that the myocardium was beating. A t test, two-sample assuming unequal variances, was performed to compare control and treated groups of explants (Microsoft Excel software).
RESULTS
Retinoic Acid Inhibits Initial Steps of EpithelialMesenchymal Cell Transformation
The transcription factor Slug is expressed in the AV canal and is required for initial steps of EMT. Slug expression within AV canal endocardium appears to be an early response to a signal emitted by AV canal myocardium (Romano and Runyan, 1999) . Previous studies have implicated several signaling factors including TGF␤2, TGF␤3, BMP, and HGF as components of the inductive signal (Potts et al., 1992; Boyer et al., 1999a; Song et al., 1999; Yamagishi et al., 1999) . TGF␤2 is required along with Slug for initial steps of EMT, whereas TGF␤3 is required for later steps of EMT (Boyer et al., 1999a) . In this study, we performed experiments to determine if BMP and HGF are required for specific steps of EMT. In addition, we tested the effect of retinoic acid on EMT. Signaling factors required for initial steps of EMT were hypothesized to be good candidates for regulating Slug expression in the heart. AV canals were dissected from Hamburger and Hamilton (1951) stage 14 chicken embryos and cultured on collagen gels in medium containing retinoic acid. After 24 h of incubation, the number of mesenchymal cells beneath the surface of the collagen gel was counted for each explant. Treatment of explants with retinoic acid resulted in a statistically significant decrease in mesenchymal cell formation compared to untreated explants (Fig. 1) . Specifically, retinoic acid treatment resulted in approximately 63% fewer mesenchymal cells than untreated explants.
Retinoic acid interfered with initial steps of EMT, including endothelial cell-cell separation. That is, the AV canal endothelial cells of retinoic acid-treated explants (Fig. 2I ) were smaller and remained in tight contact with one another compared to the AV canal endothelial cells of control explants (Fig. 2A) . In addition, fewer mesenchymal cells were observed within the collagen gel (Fig. 2J) .
We attempted to rescue the inhibitory effect of retinoic acid on EMT by adding exogenous TGF␤2. AV canals were dissected from stage 14 chicken embryos and cultured on collagen gels in medium containing both retinoic acid and TGF␤2. After 24 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant. Treatment of explants with a combination of retinoic acid and TGF␤2 produced no change in mesenchymal cell formation compared to explants treated only with retinoic acid (Fig. 3) . Therefore, TGF␤2 was not sufficient to overcome the inhibitory effect of retinoic acid on EMT.
Noggin, an Antagonist of BMP Signaling, Inhibits Later Steps of Epithelial-Mesenchymal Cell Transformation
Previous work suggests that BMP signaling is required for EMT in the heart (Yamagishi et al., 1999 ). Therefore, we tested the effect of noggin, an antagonist of BMP signaling, on EMT. AV canals were dissected from stage 13, 14, 15, or 16 chicken embryos and cultured on collagen gels in noggin-containing or control conditioned medium. After 24 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant. Noggin had no significant effect on mesenchymal cell formation in stage 13, 14, or 15 explants. However, treatment of stage 16 explants with noggin resulted in a statistically significant decrease in mesenchymal cell formation compared to untreated explants or explants cultured in control conditioned medium (Fig. 4) . Specifically, treatment of stage 16 explants with noggin resulted in approximately 30% fewer mesenchymal cells than explants cultured in control conditioned medium. The inhibitory effect of noggin on stage 16 explants was rescued by the addition of exogenous BMP-2 (Fig. 4) .
The AV canal endothelial cells of both control (Figs. 2A and 2E) and noggin-treated (Fig. 2C) stage 16 explants formed a large monolayer on the surface of the collagen gel and eventually separated from one another. However, significantly fewer mesenchymal cells were observed within the collagen gel in the presence of noggin (Fig. 2D) compared to control explants (Figs. 2B and 2F) . Therefore, BMP signaling appears to be required only for later steps of EMT such as mesenchymal cell migration. This is supported by the finding that noggin had no discernible effect on stage 13, 14, or 15 explants, although AV canal endothelial cells begin to receive an inductive signal from AV canal myocardium as early as stage 13ϩ (Ramsdell and Markwald, 1998) .
Anti-HGF Antibody Inhibits Later Steps of Epithelial-Mesenchymal Cell Transformation
HGF signaling also may be required for AV canal endothelial cells to undergo EMT (Song et al., 1999) . AV canals were dissected from Hamburger and Hamilton (1951) stage 14, 15, 16, or 17 chicken embryos and cultured on collagen gels in medium containing anti-HGF antibody. After 24 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant. The anti-HGF antibody had no effect on mesenchymal cell formation in stage 14, 15, or 16 explants. However, treatment of stage 17 explants with anti-HGF antibody resulted in a statistically significant decrease in mesenchymal cell formation compared to untreated explants (Fig. 5) . Specifically, treatment of stage 17 explants with anti-HGF antibody resulted in approximately 28% fewer mes- enchymal cells than in untreated explants. The inhibitory effect of the anti-HGF antibody on stage 17 explants was rescued by the addition of exogenous HGF (Fig. 5) .
The AV canal endothelial cells of both control explants ( Fig. 2A ) and explants treated with anti-HGF antibody (Fig.  2G) formed a large monolayer on the surface of the collagen
FIG. 2.
Retinoic acid inhibited initial steps of epithelial-mesenchymal cell transformation including endothelial cell-cell separation, while noggin and anti-HGF antibody inhibited later steps of epithelial-mesenchymal cell transformation including mesenchymal cell migration (endothelial cells, A, C, E, G, I; mesenchymal cells, B, D, F, H, J). The AV canal endothelial cells of untreated explants (A), explants cultured in noggin-containing (G) or control (E) conditioned medium, or explants treated with anti-HGF antibody (I) exhibited endothelial cell-cell separation. In contrast, the AV canal endothelial cells of explants treated with retinoic acid remained in tight contact with one another (C). Fewer mesenchymal cells were observed beneath the surface of the collagen gel when explants were treated with retinoic acid (D), noggin (H), or anti-HGF antibody (J), compared to untreated explants (B) or explants cultured in control conditioned medium (F).
gel and eventually separated from one another. However, significantly fewer mesenchymal cells were observed within the collagen gel when stage 17 explants were treated with anti-HGF antibody (Fig. 2H ) compared to control explants (Fig. 2B) . Therefore, like BMP, HGF may be required only for later steps of EMT such as mesenchymal cell migration. This is supported by the finding that the anti-HGF antibody had no discernible effect on stage 14, 15, or 16 explants.
Anti-TGF␤2 Antibody or Retinoic Acid Inhibits Slug Expression in AV Canal Explants
To determine if TGF␤2 or possibly other signaling factors regulate Slug expression during EMT in the heart, we cultured AV canal explants on collagen gels in the presence of anti-TGF␤2 antibody, anti-TGF␤3 antibody, pertussis toxin, retinoic acid, noggin, or anti-HGF antibody. RNA was collected after 24 h of incubation and used to perform semiquantitative RT-PCR. Specifically, RT-PCR was performed using specific primers designed to amplify a 358-bp Slug sequence or an 800-bp GAPDH sequence. A single band of the expected size was detected with each set of primers. No bands were detected when RT-PCR was performed without reverse transcriptase (data not shown). Twenty-seven cycles was determined to be within the linear range of both Slug and GAPDH amplification by removing and analyzing aliquots from a series of cycles (20 -35). RT-PCR was then repeated for 27 cycles using RNA collected from both untreated and treated explants. Quantification of Slug band density normalized to GAPDH levels from the same RNA samples demonstrated that only treatment with anti-TGF␤2 antibody or retinoic acid resulted in a statistically significant decrease in Slug mRNA expression compared to untreated explants (Fig. 6) .
We also performed immunostaining to show that treatment with anti-TGF␤2 antibody or retinoic acid resulted in a decrease in Slug protein expression. After 24 h of incubation, the explants were stained with a monoclonal antichicken Slug antibody. The AV canal endothelial cells of untreated explants express Slug, as do mesenchymal cells within the collagen gel (Fig. 7B) . However, staining was reduced within the endothelium of explants treated with anti-TGF␤2 antibody or retinoic acid (Figs. 7B and 7C ). No staining was observed when explants were stained for mouse IgG as a negative control (Fig. 7A) .
Slug Rescues the Inhibitory Effect of Anti-TGF␤2 Antibody but Not Retinoic Acid on EpithelialMesenchymal Cell Transformation
Treatment of AV canal explants with anti-TGF␤2 antibody or retinoic acid inhibited Slug expression, suggesting that Slug is either directly or indirectly regulated by these signaling factors. We proceeded to test whether Slug is sufficient to overcome the inhibitory effect of anti-TGF␤2 antibody or retinoic acid on initial steps of EMT. AV canals were dissected from stage 14 embryonic chicken hearts and transfected with a plasmid encoding full-length Slug and GFP (green fluorescent protein) (Fig. 8) . The plasmid was preincubated with Lipofectamine to facilitate delivery into the cells. The transfected tissue was then cultured on collagen gels in the presence of anti-TGF␤2 antibody or retinoic acid. After 48 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant.
Slug partially rescued the inhibitory effect of anti-TGF␤2 antibody but not retinoic acid on EMT (Fig. 9) . In the presence of anti-TGF␤2 antibody, transfection of explants with Slug resulted in approximately 28% more mesenchymal cells than explants transfected with control plasmid. In contrast, in the presence of retinoic acid there was no significant difference between explants transfected with Slug and explants transfected with control plasmid. Therefore, Slug is sufficient to overcome the inhibitory effect of anti-TGF␤2 antibody but not retinoic acid on initial steps of EMT.
DISCUSSION
The transcription factor Slug is required for initial steps of the EMT which occur during endocardial cushion formation (Romano and Runyan, 1999) . In the present study, we sought to identify signaling factors that regulate Slug expression in the heart in an effort to establish a pathway of genes required for EMT.
Several signaling factors are required for initial steps of EMT and, therefore, could potentially regulate Slug expression in the heart. For instance, TGF␤2 and G i proteins are required for AV canal endothelial cells to undergo initial steps of EMT. Treatment of AV canal explants with anti-TGF␤2 antibody or pertussis toxin, an antagonist of G i protein signaling, inhibited initial steps of EMT including endothelial cell-cell separation (Boyer et al., 1999a; Runyan et al., 1990) . Retinoic acid also was a good candidate for regulating Slug expression in the heart. Retinoic acid, the metabolically active form of vitamin A, alters gene expression by binding to retinoic acid receptors and retinoid X receptors (RXRs), members of the steroid superfamily of ligand-activated transcription factors (reviewed by Chambon, 1996) . RXR␣ Ϫ/Ϫ mouse embryos exhibit AV septal defects (Gruber et al., 1996) . Likewise, AV septal defects arise when embryos are exposed to inappropriate levels of retinoic acid (reviewed by Smith et al., 1998) . In this study, we found that treatment of AV canal explants with retinoic acid inhibited initial steps of EMT, including endothelial cell-cell separation, consistent with the fact that fewer mesenchymal cells were found within the endocardial cushions of chicken embryos exposed to retinoic acid (Bouman et al., 1998) . Recent findings suggest that retinoic acid inhibits EMT by interfering with the inductive signal provided by AV canal myocardium (Yan et al., 2000) . Retinoic acid also may directly affect the expression of genes in the AV canal endothelium.
Additional signaling factors are required for EMT in the heart. For instance, TGF␤3 is required for later steps of EMT including mesenchymal cell transformation (Boyer et al., 1999a) . BMP and HGF signaling also are required for EMT. BMPs are members of the TGF␤ superfamily of related growth factors. BMP-2 is expressed in the AV canal myocardium of chicken embryos (Yamagishi et al., 1999) . Treatment of AV canal explants with an antisense BMP-2 oligodeoxynucleotide inhibited EMT (Yamagishi et al., 1999) . Recently, Nakajima et al. (2000) demonstrated that a combination of TGF␤3 and BMP2 stimulated competent   FIG. 4 . Noggin, an antagonist of BMP signaling, inhibited later steps of epithelial-mesenchymal cell transformation. Stage 13, 14, 15, or 16 AV canal explants were cultured on collagen gels in noggin-containing or control conditioned medium. After 24 h of incubation, the number of mesenchymal cells within the collagen gel was counted for each explant. Noggin had no significant effect on mesenchymal cell formation in stage 13, 14, or 15 explants. However, treatment of stage 16 AV canal explants with noggin resulted in a statistically significant (P Ͻ 0.05) decrease in mesenchymal cell formation compared to untreated explants or explants cultured in control conditioned medium. The inhibitory effect of noggin on stage 16 explants was rescued by the addition of exogenous BMP-2. Error bars indicate the standard errors. endothelial cells to undergo EMT. As pharmacological doses of any TGF␤ isoform can mediate EMT (Potts and Runyan, 1989; Nakajima et al., 1998) , the significance of a particular TGF␤ isoform in this combination is limited. However, these data show a synergy between one or more TGF␤s and BMP. In the present study, we found that treatment of AV canal explants with noggin, an antagonist of BMP signaling, inhibited only later steps of EMT, including mesenchymal cell migration. The growth factor HGF is expressed in AV canal myocardium while its receptor, c-Met, is expressed in AV canal endothelium. AV canal endothelial cells cultured in vitro in the absence of AV canal myocardium undergo EMT in response to exogenous HGF (Song et al., 1999) . This is accompanied by an increase in the expression of urokinase, a protease implicated in cell motility and migration (McGuire and Alexander, 1993) . We found that treatment of AV canal explants with anti-HGF antibody also inhibited later steps of EMT.
Treatment of AV canal explants with anti-TGF␤3 antibody, noggin, or anti-HGF antibody did not inhibit Slug expression, consistent with the finding that these signaling factors are required only for later steps of EMT in the heart. However, BMP and HGF signaling have been shown to regulate Slug expression in other tissues. BMP signaling from adjacent nonneural ectoderm regulates Slug expression in the neural crest of chicken embryos (Liem et al., 1995; Selleck et al., 1998) . Previous work demonstrated that Slug also is a downstream target of HGF signaling during the transformation of rat NBT-II bladder carcinoma cells. The addition of exogenous HGF can induce NBT-II cells to undergo EMT in vitro. NBT-II cells transfected with Slug cDNA completed initial steps of transformation. However, NBT-II cells transfected with antisense Slug cDNA did not transform into mesenchymal cells and resisted induction by HGF (Savagner et al., 1997) . Although Slug appears to play a conserved role in EMT, these data suggest that the signaling factors that regulate Slug expression during EMT are tissue-dependent.
We found that only treatment of explants with anti-TGF␤2 antibody or retinoic acid inhibited Slug expression. These data are consistent with the fact that TGF␤2 is required along with Slug for initial steps of EMT. In addition, they are consistent with the fact that retinoic acid was shown in this study to inhibit initial steps of EMT. Retinoic acid has been shown to inhibit Slug expression in the chicken limb bud as well. Within the limb bud, Slug is expressed in the progress zone, an area of undifferentiated, rapidly proliferating mesenchymal cells subjacent to the apical ectodermal ridge (Buxton et al., 1997; Ros et al., 1997) . Implantation of retinoic acid beads inhibited Slug expression in the progress zone (Buxton et al., 1997) . It is interesting to note that neural crest defects are associated with exposure of embryos to abnormal levels of retinoic acid (reviewed by Smith et al., 1998) . It is possible that retinoic acid also disrupts Slug expression in presumptive neural crest cells, including those that contribute to the outflow tract region of the heart.
Transfection of AV canal explants with Slug did not rescue the inhibitory effect of retinoic acid on EMT. Slug may not have been sufficient to overcome the inhibitory effect of retinoic acid on EMT because it was only one of several genes disrupted by retinoic acid exposure. Exposure of embryos to abnormal levels of retinoic acid appears to have a widespread effect on gene expression. For instance, abnormal levels of retinoic acid have been shown to disrupt the development of many tissues, including the neural crest, heart, eyes, limbs, and nervous system (reviewed by Smith et al., 1998) . The recent demonstration that retinoic acid disrupts ECM secretion by the myocardium suggests that expression of Slug is unable to overcome the loss of one or more components of the inductive signal provided by the myocardium (Yan et al., 2000) .
In contrast, Slug is sufficient to rescue the inhibitory effect of anti-TGF␤2 antibody on EMT. Therefore, Slug appears to be an essential target of TGF␤2 signaling during initial steps of EMT in the heart. TGF␤2 signaling may regulate Slug expression through activation of the Type III TGF␤ receptor. Treatment of AV canal explants with a blocking antibody specific for the Type III TGF␤ receptor inhibited initial steps of EMT (Brown et al., 1999) . In contrast, treatment of AV canal explants with a blocking antibody specific for the Type II TGF␤ receptor inhibited distinctly later steps of EMT (Brown et al., 1996) . Thus, TGF␤2 appears to regulate initial steps of EMT via activation of the Type III TGF␤ receptor, while TGF␤3 appears to regulate later steps of EMT via activation of the Type II TGF␤ receptor. The Type III TGF␤ receptor, also known as betaglycan, has no known signaling domain (Wang et al., 1991; Lopez-Casillas et al., 1991) and was presumed only to "present" ligand to other TGF␤ receptors (Lopez-Casillas et al., 1993) . However, recent work suggests that the Type III TGF␤ receptor is capable of signal transduction (Brown et al., 1999) . Regulation of Slug expression by TGF␤2 but not TGF␤3 demonstrates the ability of target AV canal endothelial cells to distinguish between the different endogenous TGF␤ signal transduction pathways involved in EMT and is consistent with the suggestion of regulation by betaglycan. This pattern of ligand and receptor activity (i.e.,
FIG. 8.
A plasmid encoding full-length Slug and GFP was constructed to rescue AV canal explants treated with anti-TGF␤2 antibody or retinoic acid. Full-length Slug cDNA (829 bp) was cloned into the Clontech bicistronic expression vector pIRES2-EGFP (5.3 kb) using EcoRI and BamHI restriction enzymes. This vector permits both Slug and EGFP to be translated from a single RNA due to the presence of an internal ribosome entry site (IRES).
FIG. 9.
Slug rescued the inhibitory effect of anti-TGF␤2 antibody but not retinoic acid on epithelial-mesenchymal cell transformation. AV canals were dissected from stage 14 chicken embryo hearts and transfected with a plasmid encoding full-length Slug and GFP. The explants were incubated for 48 h on collagen gels in the presence of anti-TGF␤2 antibody or retinoic acid. The number of mesenchymal cells within the collagen gel was then counted for each explant. Transfection of explants with Slug resulted in a statistically significant increase in mesenchymal cell formation (P Ͻ 0.05) in the presence of anti-TGF␤2 antibody, compared to explants transfected with control plasmid. No significant difference was observed between explants transfected with Slug and explants transfected with control plasmid in the presence of retinoic acid.
TGF␤2 with TGF␤ Type III receptor and TGF␤3 with TGF␤ Type II receptor) is further demonstrated by specific regulation of a variety of markers in cardiac cushion development (Boyer et al., 1999b; Boyer et al., in preparation) .
In summary, several signaling factors are expressed in the AV canal and are required for EMT. Previous studies along with data presented here indicate that these signaling factors are required for specific steps of EMT (Boyer et al., 1999a) . TGF␤3, BMP, and HGF signaling is required for later steps of EMT. In contrast, TGF␤2 and G i protein signaling is required along with Slug for initial steps of EMT. Our data indicate that AV canal endothelial cells are also sensitive to retinoic acid during initial steps of EMT. However, only TGF␤2 and retinoic acid were shown to regulate Slug expression in the heart. Although G i protein signaling is required along with Slug for initial steps of EMT, pertussis toxin failed to inhibit Slug expression. The signaling factors involved in initial steps of EMT thus appear to regulate the expression of different or overlapping sets of genes. Additional studies are necessary to identify specific G protein-linked receptors and their downstream targets in the heart.
These data contribute to a model in which AV canal endothelial cells undergo EMT in response to multiple, independent signaling pathways. Identification of additional components of these signal transduction pathways will contribute to a better understanding of EMT. For instance, several transcription factors including Brachyury, Msx-1, and Mox-1 are expressed in the heart and have been shown to play a role during EMT in other tissues (reviewed by Huang et al., 1995) . One or more of these transcription factors may be required along with Slug for the EMT which occurs in the AV canal. Future studies of EMT also appear to be critical for understanding metastasis. Interestingly, Snail, a transcription factor related to Slug, was recently shown to repress the expression of E-cadherin in invasive carcinoma tissues in mouse embryos (Batlle et al., 2000; Cano et al., 2000) .
